Tag: FDA guidance 2025
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
The FDA's 2025 guidance streamlines biosimilar approval by replacing costly clinical trials with advanced analytical data, accelerating access to lower-cost biologic alternatives for cancer, arthritis, and diabetes. Learn how the process works and what's still holding it back.
view morerecent posts
Stimulants like Adderall and Ritalin help manage ADHD but can increase the risk of dangerous heart rhythms, especially in older adults or those with hidden heart conditions. Learn how to assess your risk and what safer alternatives exist.
Published ON: 18 MarCombining sedating medications like opioids and benzodiazepines can lead to deadly respiratory depression. Learn the warning signs, dangerous combinations, and how to reduce your risk safely.
Published ON: 1 MarSwitching to generic medications saves up to 85% on prescription costs without sacrificing safety or effectiveness. Backed by FDA data and real patient outcomes, generics are the smart choice for long-term health and budgeting.
Published ON: 16 MarBacterial and viral infections look similar but require completely different treatments. Antibiotics work on bacteria, not viruses-and misuse fuels dangerous drug resistance. Learn how to tell them apart and what to do when you're sick.
Published ON: 2 MarLearn how to search FDA's Drugs@FDA database to find official drug approval records, labels, and review documents. No registration needed - just use the main search box to get accurate, up-to-date information on FDA-approved medications.
Published ON: 15 Mar